| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/24/1986 | WO1986002354A1 Monoclonal antibodies and their use |
| 04/24/1986 | WO1986002353A1 Dipeptide compounds having pharmaceutical activity and compositions containing them |
| 04/24/1986 | WO1986002274A1 Apparatus, substance and method for treatment for the immune system |
| 04/24/1986 | WO1986002271A1 Promotion of wound healing with human epidermal growth factor prepared from recombinant dna |
| 04/23/1986 | EP0179023A2 With micro-organisms degradable polypeptide, and its use for the progressive release of medicaments |
| 04/23/1986 | EP0179006A1 Process for the preparation of the FVIII/vWF complex for therapeutical use, and resulting products |
| 04/23/1986 | EP0178927A2 Compounds, methods for their preparation, and their use in therapy |
| 04/23/1986 | EP0178867A2 Novel hormones and methods for making, using and assaying same |
| 04/23/1986 | EP0178845A2 Peptide-substituted heterocyclic immunostimulants |
| 04/23/1986 | EP0178841A2 Intragonadal regulatory protein |
| 04/23/1986 | EP0178775A2 Fluorescent indicator dyes for calcium ions |
| 04/23/1986 | EP0178676A2 Antigenic peptide compounds |
| 04/23/1986 | EP0178665A2 Stable erythropoietin preparation and process for formulating the same |
| 04/23/1986 | EP0178600A1 Use of a combination of tetrahydrobiopterins and lymphokines for the manufacture of a medicament possessing an enhanced in vivo and in vitro lymphokine activity |
| 04/23/1986 | EP0178576A1 Method and composition for preventing the adsorption of a medicine |
| 04/23/1986 | EP0178321A1 Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch |
| 04/22/1986 | US4584294 Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents |
| 04/22/1986 | US4584285 (benzothiadiazine benzamido and benzenesulfonyl)-phenyl-substituted carboxyalkyl dipeptides |
| 04/22/1986 | US4584284 Bursopoietin |
| 04/22/1986 | US4584130 Physiolgically competent oxygen carrier |
| 04/22/1986 | CA1203483A1 Pharmaceutical composition |
| 04/22/1986 | CA1203479A1 Process of separating or purifying a sleep promoting factor from a biological medium by an immunological reaction of the antigen-antibody type |
| 04/22/1986 | CA1203478A1 Plasma fractionating process |
| 04/22/1986 | CA1203477A1 Purification of antihemophilia factor viii by precipitation with zinc ions |
| 04/22/1986 | CA1203476A1 Stabilized insulin solutions and method for their production |
| 04/22/1986 | CA1203475A1 Use of thymosin as an anti-autoimmune and anti- hypertensive disease agent |
| 04/22/1986 | CA1203474A1 Therapeutic compositions for the treatment of contact allergies |
| 04/16/1986 | EP0178105A2 Recombinant DNA techniques and the products thereof |
| 04/16/1986 | EP0178050A1 Proteinaceous substance |
| 04/16/1986 | EP0177957A2 Expression of biologically active platelet derived growth factor analogs in eucaryotic cells |
| 04/16/1986 | EP0177910A2 Use of preparations containing gamma-interferon (IFN-gamma) for systematically treating various human diseases at a low dosage |
| 04/16/1986 | EP0177882A2 Antibiotic A 40926 complex and its pure factors PA, PB, A, B and BO |
| 04/16/1986 | EP0177826A2 Medicament and diagnostic agent with a growth hormone releasing factor activity |
| 04/16/1986 | EP0177819A2 Growth hormone releasing factor analogs and process therefore |
| 04/16/1986 | EP0177814A2 Peptide antibodies and their use in detecting oncogene products |
| 04/16/1986 | EP0177771A2 Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of Actinoplanes |
| 04/16/1986 | EP0177685A2 Method for pasteurizing plasma proteins, particularly plasma protein fractions |
| 04/16/1986 | EP0177610A1 Atrial peptide analogs |
| 04/15/1986 | US4582820 Orally administered biologically active peptides and proteins |
| 04/15/1986 | US4582800 Interferon cloned onto bacteria plasmid |
| 04/15/1986 | US4582639 Antitumor antibiotic compound |
| 04/15/1986 | EP0164397A4 A buffered polyol-hormone mixture for use in chronic parenteral hormone administration. |
| 04/15/1986 | CA1203169A1 Method of preparation of pure antigene hbs from human plasma |
| 04/15/1986 | CA1203166A1 Pasteurized human fibrinogen (hf), a process for its preparation and its use |
| 04/10/1986 | WO1986002100A1 Vectors containing a gene for a protein having erythroid-potentiating activity and recombinant dna methods for producing said protein |
| 04/10/1986 | WO1986002098A1 Anti-leishmania monoclonal antibodies, hybridomas secreting said antibodies, antigens of leishmania recognized by said antibodies, method for obtaining them and applications of said monoclonal antibodies and said antigens |
| 04/10/1986 | WO1986002081A1 Acino-foetal differentiation proteins associated to the pancreas cancer, antiserum and monoclonal antibodies to said proteins, preparation methods |
| 04/10/1986 | WO1986002079A1 Pharmacologically active peptide |
| 04/09/1986 | EP0177478A2 Prolonged release of biologically active somatotropins |
| 04/09/1986 | EP0177366A2 Enkephalinase B inhibitors, their preparation, and pharmaceutical compositions containing the same |
| 04/09/1986 | EP0177342A2 Oral formulation of therapeutic proteins |
| 04/09/1986 | EP0177153A2 Interferon-cyclaradine combination |
| 04/09/1986 | EP0176999A2 Amino acid derivatives, process for their preparation and pharmaceutical compositions |
| 04/09/1986 | EP0176926A2 Process for producing a high purity antihemophilic factor concentrate |
| 04/09/1986 | EP0176916A2 Process for production of gamma-interferon |
| 04/09/1986 | EP0176913A2 Glycourethane derivatives, methods for their preparation and their use |
| 04/09/1986 | EP0176903A1 Thiomorpholines |
| 04/09/1986 | EP0176780A1 A preservative solution for fixed avian erythrocytes for the viral hemagglutination test |
| 04/09/1986 | EP0176769A2 Medicine for treating carcinomas |
| 04/08/1986 | US4581231 Contacting with a halohydrocarbon solvent or treating agent |
| 04/08/1986 | US4581169 Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists |
| 04/08/1986 | US4581168 Synthesis of hpGRF (Somatocrinin) in liquid phase and intermediate peptides |
| 04/08/1986 | US4581166 Extraction at low temperature and pressure between the critical pr |
| 04/08/1986 | US4581165 Anti-diabetic compounds |
| 04/08/1986 | CA1202917A1 Process for producing subculturable lymphokine- producing human t cell hybridomas |
| 04/08/1986 | CA1202902A1 Composition and method for increasing brain tyrosine levels |
| 04/08/1986 | CA1202896A1 Antigen drug and process of producing it for therapy of nonspecific allergic diseases |
| 04/08/1986 | CA1202895A1 Thrombolytic composition |
| 04/02/1986 | EP0176436A2 Analogs of substance P and eledoisin |
| 04/02/1986 | EP0176429A1 Compositions and process for protecting T lymphocytes against the etiological agent of lymphadenopathy and an acquired immunodepression syndrom |
| 04/02/1986 | EP0176365A2 Human monoclonal antibody and its preparation |
| 04/02/1986 | EP0176094A1 Parenteral alimentation solution |
| 04/02/1986 | EP0176070A1 Pharmacologically active peptides |
| 04/02/1986 | EP0175786A1 Pure chymopapain b: industrial process and therapeutic composition |
| 04/02/1986 | EP0175714A1 A method of treating hypoglycemia in vertebrates |
| 04/02/1986 | EP0175705A1 Macrophage activating factor |
| 04/01/1986 | US4579840 Method of blocking immune complex binding to immunoglobulin Fc receptors |
| 04/01/1986 | US4579820 Process for enzymatic replacement of the B-30 amino acid in insulins |
| 04/01/1986 | US4579735 Process for the pasteurization of human residual plasma |
| 04/01/1986 | US4579730 Oral administration; insulin bile acid or salt and protease inhibitor |
| 04/01/1986 | CA1202587A1 Semi-synthetic preparation of human insulin |
| 04/01/1986 | CA1202585A1 Process for preparing substance having carcinostatic and immunostimulating activity |
| 03/27/1986 | WO1986001834A1 Retroviral polypeptides associated with human cellular transformation |
| 03/27/1986 | WO1986001808A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001807A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001806A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001805A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001804A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001803A1 Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them |
| 03/27/1986 | WO1986001723A1 Method of rectification of human leukocytic interferon |
| 03/27/1986 | WO1986001722A1 Method of obtaining human leukocytic interferon |
| 03/27/1986 | WO1986001719A1 Medicinal composition and method for the treatment of periarthritis and similar diseases |
| 03/27/1986 | WO1986001718A1 METHOD FOR OBTAINING THE COMPLEX FVIII/vWF OF THERAPEUTIC USE AND PRODUCTS RESULTING THEREFROM |
| 03/26/1986 | EP0175644A2 New pharmaceutical use of somatostatin analogues |
| 03/26/1986 | EP0175506A2 GnRH antagonists |
| 03/26/1986 | EP0175498A2 Peptides, their use in medicine and methods for their preparation |
| 03/26/1986 | EP0175360A2 Peptide antibodies and their use in detecting oncogene products |
| 03/26/1986 | EP0175323A2 Biologically active peptides, processes for preparing them and pharmaceutical compositions |
| 03/26/1986 | EP0175290A2 Glycopeptides, method for their preparation and their use |
| 03/26/1986 | EP0175289A2 Treatment of diarrhoea with alpha-interferons |